Fund Holdings — Carlyle Group Inc.

Total Portfolio Value
$10.62B
Total Bought
$497.3K
Total Sold
$2.91B
Net Transaction
-$2.91B
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Q32 Bio Inc(FIXX)1,102,7411,102,74103,6177,0800.07%+3,463
Heartflow Inc(HTFL)020,438+20,43804970.00%+497
Onkure Therapeutics Inc(OKUR)269,895269,89507721,1170.01%+345
Spyre Therapeutics Inc(SYRE)9,6209,62003154850.00%+170
CubeSmart(CUBE)220,500220,50007,9498,0810.08%+132
Exicure Inc(XCUR)56,32856,32803052400.00%-65
SunPower Inc(SPWR)433,158433,15806805500.01%-130
Robinhood Mkts Inc(HOOD)3,3763,37603822340.00%-148
Krispy Kreme Inc(DNUT)340,748340,74801,3701,1550.01%-215
N-able Inc(NABL)93,73293,73207014380.00%-263
Adicet Bio Inc184,295184,29501,5441,2550.01%-289
Nucana Plc(NCNA)133,3330-133,3334800—-480
Spruce Biosciences Inc38,62038,62003,2992,5240.02%-775
Jasper Therapeutics Inc(JSPR)1,066,1891,066,18901,9409340.01%-1,006
Forward Air Corp(FWRD)107,214107,21403,0941,7920.02%-1,302
Invitation Homes Inc(INVH)664,100664,100018,45516,5030.16%-1,952
Getty Images Holdings Inc(GETY)6,234,2526,234,25208,3544,9460.05%-3,408
Pony Ai Inc(PONY)2,362,4472,362,447034,25522,3020.21%-11,954
Phathom Pharmaceuticals Inc(PHAT)3,496,8083,496,808057,97738,8500.37%-19,128
Medline Inc(MDLN)215,303,036187,083,713-28,219,3239,042,7288,325,22578.40%-717,502
Standardaero Inc(SARO)152,673,89184,587,035-68,086,8564,378,6872,184,88320.58%-2,193,804
Page 1 of 1
Carlyle Group Inc. — 13F Holdings — Q1 2026 | TickerTrail